|Videos|August 12, 2011

Prescription Acetaminophen-Opioid Combinations: Making Pain Medicines Safer

Sandy Kweder, deputy director of the FDA's Office of New Drugs, talks about the implications of the FDA's announcement earlier this year that all prescription combinations of opioids and acetaminophen are required to contain no more than 325 mg of acetaminophen per tablet.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!

Latest CME

Panel Discussion Registration

An American Journal of Managed Care Forum: Bridging Evidence and Access in Advanced Small Cell Lung Cancer

December 10, 2025 | 1:00 PM - 2:30 PM ET

Prescription Acetaminophen-Opioid Combinations: Making Pain Medicines Safer

Newsletter

Related Content

Pneumococcal Booster Vaccination Is Necessary in Patients With Sickle Cell Disease

Automation and Standardization Take Center Stage in Health System’s Centralized IV Compounding Strategy

Prescriber Incentives Drive Shifts in Nicotine Replacement Therapy Use at Discharge

Asundexian Reduces Risk of Future Ischemic Stroke as Secondary Prevention

Opinion: To Succeed, Direct-to-Patient Drug Sales Will Require Better Technology

Latest CME

An American Journal of Managed Care Forum: Bridging Evidence and Access in Advanced Small Cell Lung Cancer

The Role of the Pharmacist Migraine Management

Continuing the Conversation: Pharmacist Interventions to Optimize T2D Care and Break Through Clinical Inertia

Combating Opioid Overdoses: The Impact of Pharmacist-led Counseling and Dispensing of Opioid Reversal Agents

New and Approved: FDA’s 2024 Drug Lineup

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Pharmacy Technician Credit)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Pharmacy Technician Credit)

Implementing Updated RSV Vaccination Recommendations for Older Adults: RSV Case Discussion

Exploring HIV Long-Acting Injectable Uptake: How Pharmacists Can Encourage Long-Acting Injectables to Stem the Spread of HIV

Best Practices for Management of Hyperlipidemia: A Focus on Guidelines and Patient Adherence

Optimizing LDL-C Lowering and Adherence to Hyperlipidemia Guidelines

The Role of the Pharmacist in the Management of Hyperlipidemia

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based Regimens

Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative

Optimizing the Uptake of Long-Acting Injectables in HIV Treatment and Prevention: Considerations for Managed Care

Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care

Managed Care Approaches and Models for Equitable Access to Innovations in Major Depressive Disorder Treatment

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

Continuous Glucose Monitoring: What's New in 2025?

Advancing Stroke Prevention: The Pharmacist’s Role in Implementing the 2024 Guidelines

Beyond the Prescription: Tackling Social Isolation for Better Health (Pharmacy Technician Credit)

Understanding and Personalizing Chronic Obstructive Pulmonary Disease Diagnosis and Treatment

Balancing Pain Management and Opioid Use Disorder: Recognition, Treatment, and Compassionate Communication in Pharmacy Practice

Advancing Multiple Sclerosis Treatment: Exploring Evolving Therapies and Patient-Centered Approaches

Identifying and Personalizing Iron Deficiency Anemia Treatment in Patients With Cancer

Managing Iron Replacement Therapies for Patients With Inflammatory Bowel Disease

Iron Deficiency Anemia Treatment Considerations in Women’s Health

Exploring ATTR Phenotypes and Identifying Appropriate Opportunities for Pharmacists to Intervene

The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes

Advances in Castration-Sensitive Prostate Cancer: A Pharmacist's Approach to Optimize Novel Antiandrogen Therapies

Securing the Supply Chain: The Pharmacists’ Role in DSCSA Compliance

VMAT2 Inhibitors for Long-Term Success in Tardive Dyskinesia

Navigating Adverse Effects in HR+/HER2-Negative Metastatic Breast Cancer: Tailored Management Plans and Pharmacist Interventions for Improved Outcomes

Shaping the Future of Generalized Myasthenia Gravis Management: A Focus on Novel Treatment Approaches

Chronic Obstructive Pulmonary Disease and Inflammation: Practical Approaches to Integrating Biologic Therapy

Updated Guidance and Managed Care Strategies to Optimize Care in EGFR Mutated NSCLC

Addressing the Burden of Hemolysis in Paroxysmal Nocturnal Hemoglobinuria: The Pharmacist's Contribution to Patient Care

Redefining Complement-Mediated Kidney Disease: The Latest in Diagnosis and Treatment

Reducing Transfusion Burden in Myeloid Disorders: Novel Therapeutic Strategies and Pharmacist Interventions

Panel Discussion: Integrating Novel Combinations and Earlier Line Use in Diffuse Large B-Cell Lymphoma

Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)

Navigating the New Wave in Targeted Therapies for Acute Myeloid Leukemia: A Focus on IDH and FLT3 Mutations

Understanding the Pearls and Pitfalls of Nimodipine in Aneurysmal Subarachnoid Hemorrhage: Opportunities to Improve Patient Outcomes

Demystifying CGM: Addressing Frequently Asked Questions and Key Insights (Pharmacy Technician Credit)

Advancements With CGM Integrations: Insulin Pumps, Connected Pens, and Ketone Monitoring (Pharmacy Technician Credit)

The Role of IV Iron in Resolving Iron Deficiency in Heart Failure

Advances and Innovations in Hypertrophic Cardiomyopathy Management: A Focus on New and Emerging Therapies

Empowering Pharmacists in Travel Medicine: Enhancing Patient Care Through Vaccination, Prevention, and Education (Pharmacy Technician Credit)

Oncology Pharmacists Connect 2026

The Changing Paradigm in Pain Management and Supporting Access to Novel Therapies

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

Clinical Panel Debate: CAR T-Cell Therapy vs Bispecific Antibodies

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians

Targeting the Root of Autoimmunity in Generalized Myasthenia Gravis: Pharmacist Strategies for Integrating FcRn Therapies Into Specialty Practice

New Horizons in ATTR-CM: Therapeutic Advances and Strategic Insights

Navigating Advanced Prostate Cancer Treatment: Optimizing Novel Therapeutic Strategies for Managed Care Pharmacists

Overview and Burden of Migraine

Mastering Hypertrophic Cardiomyopathy: Cutting-Edge Therapies for Better Outcomes

ASHP Midyear 2025

Revolutionizing Acute Pain Relief: Emerging Non-Opioid Therapies and the Essential Role of Pharmacists

Optimizing Bispecific Antibody Therapy in Relapsed/Refractory Lymphomas: A Practical Guide for Pharmacists

Advancements in Extensive-Stage Small Cell Lung Cancer Therapy: Integrating Clinical Evidence to Fill Gaps in Care

The Evolving Treatment Landscape of Migraine

Guiding Bispecific Antibody Use in Non-Hodgkin Lymphoma: Integrating Evidence and Enhancing Care

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

HER2 in Focus: Biomarker Insights and Therapeutic Advancements Across Solid Tumors

Emerging Biologic Therapy for the Management of COPD: Integrated Approaches to Optimized Care